Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

16-193 - Laxton v. Teva Pharmaceuticals USA Inc


Download Files

Metadata

Document in Context
16-193 - Laxton v. Teva Pharmaceuticals USA Inc
July 8, 2016
PDF | More
CLERK'S ORDER (GJL) - Due to electronic case opening, the above numbered case was inadvertently opened in error. Therefore, this case will be administratively closed. The new case number in the Southeastern Division is 1:16cv193 ACL
November 28, 2016
PDF | More
MEMORANDUM AND ORDER re:23 MOTION to Dismiss Case and Memorandum of Law in Support filed by Defendant Teva Pharmaceuticals USA Inc. IT IS HEREBY ORDERED that defendants' motion to dismiss (#23) is GRANTED in part. Signed by District Judge Stephen N. Limbaugh, Jr on 11/28/16. (CSG)
March 8, 2017
PDF | More
MEMORANDUM AND ORDER re:38 MOTION to Dismiss for Lack of Jurisdiction filed by Defendant Sylvia Matthews Burwell, Defendant Robert Califf, Defendant Food and Drug Administration. IT IS HEREBY ORDERED that defendants' motion to dismiss (#38) is GRANTED. IT IS FURTHER ORDERED that in light of this Court's November 28, 2016 Memorandum and Order, this matter will be dismissed in its entirety. Signed by District Judge Stephen N. Limbaugh, Jr on 3/8/17. (CSG)